36 studies found for:    Lyme disease | "Borrelia Infections"
Show Display Options
Rank Status Study
21 Recruiting Analysis of Lyme Disease Lesions
Conditions: Erythema Migrans Lesions;   Erythema Migrans
Intervention:
22 Completed Doxycycline in Therapy of Erythema Migrans
Condition: Lyme Borreliosis
Intervention: Drug: Doxycycline
23 Enrolling by invitation Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis
Condition: Neuroborreliosis, Borrelia Burgdorferi
Interventions: Drug: Doxycycline;   Drug: Placebo
24 Recruiting Study on Early Lyme Neuroborreliosis
Condition: Nervous System Lyme Borreliosis
Intervention: Drug: ceftriaxone
25 Completed Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever
Conditions: Relapsing Fever, Tick-Borne;   Jarisch Herxheimer Reaction
Intervention: Drug: doxycycline treatment
26 Completed Phase 1/2 Lyme Vaccine Study
Condition: Prophylaxis of Lyme Borreliosis
Intervention: Biological: Multivalent recombinant OspA Lyme Borreliosis Vaccine
27 Unknown  Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis
Condition: Suspected Early Lyme Neuroborreliosis
Interventions: Drug: doxycycline;   Drug: ceftriaxone
28 Active, not recruiting Antibiotic Treatment of Multiple Erythema Migrans
Condition: Multiple Erythema Migrans
Interventions: Drug: ceftriaxone;   Drug: doxycycline;   Other: erythema migrans patients treated with doxycycline
29 Recruiting Cytokines and Chemokines in Erythema Migrans
Condition: Erythema Migrans
Intervention: Drug: antibiotic treatment
30 Completed
Has Results
Duration of Antibiotic Treatment of Erythema Migrans
Condition: Erythema Chronicum Migrans
Interventions: Drug: doxycycline;   Drug: placebo
31 Unknown  Study of Lyme Neuroborreliosis
Condition: Lyme Neuroborreliosis
Interventions: Drug: Doxycycline;   Drug: Ceftriaxone
32 Completed Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
Condition: Lyme Neuroborreliosis
Interventions: Drug: Ceftriaxone;   Drug: Doxycycline
33 Recruiting Laboratory Characteristics in Chronic Atrophic Acrodermatitis
Condition: Chronic Atrophic Acrodermatitis
Interventions: Drug: doxycycline orally, 100 mg, bid, 14 days;   Drug: doxycycline orally, 100 mg, bid, 28 days
34 Active, not recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)
Conditions: Visceral Leishmaniasis;   Human African Trypanosomiasis;   Enteric Fever;   Melioidosis;   Brucellosis;   Leptospirosis;   Relapsing Fever;   Rickettsial Diseases;   HIV;   Tuberculosis;   Malaria;   Amoebic Liver Abscess
Interventions: Device: rk28 ICT;   Device: IT LEISH (rK39);   Device: Immunochromatographic HAT test;   Device: HAT Serostrip;   Device: Card Agglutination Trypanosoma Test (CATT)-10;   Device: Typhidot M;   Device: S. typhi IgM/IgG;   Device: Test-it Typhoid IgM;   Device: Test-it Leptospirosis IgM;   Device: Leptospira IgG/IgM
35 Recruiting Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Conditions: Infection;   Hypertension;   Pain;   Reflux;   Edema;   Hyperlipidemia;   Hypotension;   Hypercholesterolemia;   Sedation;   Anxiolysis;   Benzodiazepine Withdrawal;   Bipolar Disorder;   Autistic Disorder;   Schizophrenia;   Influenza Treatment or Prophylaxis;   Acute Decompensated Heart Failure;   Stable Angina;   Life-threatening Fungal Infections;   Nosocomial Pneumonia;   Community Acquired Pneumonia;   Acute Bacterial Exacerbation of Chronic Bronchitis;   Complicated Skin and Skin Structure Infections;   Uncomplicated Skin and Skin Structure Infections;   Chronic Bacterial Prostatitis;   Complicated Urinary Tract Infections;   Acute Pyelonephritis;   Uncomplicated Urinary Tract Infections;   Inhalational Anthrax (Post-Exposure);   Infantile Hemangioma;   Withdrawal;   Inflammation;   Bacterial Septicemia;   Cytomegalovirus Retinitis;   Herpes Simplex Virus;   Adenovirus;   Brain Swelling;   Airway Swelling;   Adrenal Insufficiency;   Anxiety;   Nausea;   Vomiting;   Convulsions;   Muscle Spasms;   Seizures;   Epilepsy;   Bartonellosis;   Brucellosis;   Cholera;   Plague;   Psittacosis;   Q Fever;   Relapsing Fever;   Rocky Mountain Spotted Fever;   Trachoma;   Tularemia;   Typhus Fever;   Bronchospasm;   Cardiac Arrest;   Hypersensitivity Reaction;   Cyanide Poisoning;   Acute Bacterial Sinusitis;   Bacterial Meningitis;   Sepsis;   Gastroparesis;   Opioid Addiction;   Migraines;   Headaches
Intervention: Drug: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:
36 Completed Microbiologic Findings of Acute Facial Palsy in Children
Condition: Facial Paralysis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Indicates status has not been verified in more than two years